NCT07331324

Brief Summary

The purpose of this research study is to determine whether COMA-F is more efficacious at reducing emotional distress in caregivers of patients with severe acute brain injuries, compared to health education control.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
56mo left

Started May 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2025

Completed
24 days until next milestone

First Posted

Study publicly available on registry

January 9, 2026

Completed
4 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2030

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2030

Last Updated

February 20, 2026

Status Verified

February 1, 2026

Enrollment Period

4.3 years

First QC Date

December 16, 2025

Last Update Submit

February 18, 2026

Conditions

Keywords

caregiversemotional distresscaregiver burdenresiliencecomasevere acute brain injurymindfulness

Outcome Measures

Primary Outcomes (1)

  • Hospital anxiety and depression scale

    Measures anxiety and depression. Anxiety and depression sub scales each range from 0 (minimum) to 21 (maximum) with higher scores meaning worse outcome.

    baseline, 6-weeks, and 3-month follow-up

Secondary Outcomes (2)

  • Posttraumatic stress disorder checklist-5

    baseline, 6-weeks, and 3-month follow-up

  • World Health Organization Quality of Life-Short Form

    baseline, 6-weeks, and 3-month follow-up

Other Outcomes (5)

  • Cognitive and Affective Mindfulness Scale

    baseline, 6-weeks, and 3-month follow-up

  • Applied Mindfulness Process Scale

    baseline, 6-weeks, and 3-month follow-up

  • Measure of Current Status-A

    baseline, 6-weeks, and 3-month follow-up

  • +2 more other outcomes

Study Arms (2)

Coma Family Program 1

EXPERIMENTAL

This arm provides skills training to manage distress, uncertainty, and long-term caregiving challenges.

Behavioral: Coma Family Program 1

Coma Family Program 2

PLACEBO COMPARATOR

This arm involves providing education about managing caregiving distress, uncertainty, and long-term challenges.

Behavioral: Coma Family Program 2

Interventions

This intervention provides skills training to manage distress, uncertainty, and long-term caregiving challenges.

Coma Family Program 1

This involves education (but no skills training) about managing caregiving distress, uncertainty, and long-term challenges.

Coma Family Program 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older - study population
  • English fluency and literacy - measures and intervention are in English
  • Screens positive for emotional distress on either depression or anxiety subscales (\>7) of the Hospital Anxiety and Depression scale - study population (caregivers must be at-risk for chronic distress via heightened acute distress)
  • Confirmed by the clinical team as the primary caregiver of a patient who has been admitted to an intensive care unit (ICU) with a severe acute brain injury with the following characteristics:
  • years or older - study population
  • Admitted with ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, traumatic brain injury, or hypoxic-ischemic encephalopathy - study population
  • Glasgow Coma Scale score below 9 (in judgement of the clinical team) while not intubated or an inability to follow meaningful commands while intubated at any point during the hospitalization for \> 24 consecutive hours due to the brain injury itself and not a confounding factor (e.g., sedation or seizures) - study population
  • Still alive in ICU at the time the clinical team approaches the caregiver about possible recruitment - excludes caregivers of those that passed away as would require a different intervention (e.g., grieving intervention)
  • Has been committed to or has already received long-term life-sustaining treatments including tracheostomy and/or percutaneous endoscopic or surgical gastrostomy tube placement (trach or PEG) - study population; at time of enrollment patients can be in various early stages of cognitive/functional recovery from initial coma, but all were severe enough to require trach and/or PEG
  • Has a prognosis for survival of greater than 3 months and does not have a concurrent diagnosis of a terminal illness or injury as judged by the clinical team - as in "d"; such caregivers would require different intervention
  • Is still in ICU or has been transferred to a lower level of care (e.g., stepdown) for \<7 days at the time of consent - study population; we aim to begin the intervention when caregivers are acutely distressed in the context of the patient's ICU stay or shortly after the ICU stay (i.e., within 7 days of leaving)

You may not qualify if:

  • \. Serious mental illness, substance misuse, or active suicidal intent or plan - requires higher level of care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

University of Maryland School of Medicine

Baltimore, Maryland, 21201, United States

Location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

University of North Carolina School of Medicine

Chapel Hill, North Carolina, 27599, United States

Location

MeSH Terms

Conditions

ComaBrain InjuriesCaregiver Burden

Condition Hierarchy (Ancestors)

UnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBrain DiseasesCentral Nervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesStress, PsychologicalBehavioral SymptomsBehavior

Central Study Contacts

Alexander M Presciutti, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Member of the Faculty

Study Record Dates

First Submitted

December 16, 2025

First Posted

January 9, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

August 1, 2030

Study Completion (Estimated)

December 1, 2030

Last Updated

February 20, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

Data includes caregiver demographic characteristics, health characteristics (quality of life), and outcome assessments (e.g., emotional distress, coping, mindfulness, etc). These measures will be self-reported. We will also collect limited quantitative data extracted from patients' medical charts (diagnosis, age, race, ethnicity). All data will be de-identified and preserved for at least seven years after closing the study with IRB. Quantitative datasets will be made available via the Vivli database.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
All de-identified data will be preserved for at least seven years after closing the study with IRB.
Access Criteria
The de-identified quantitative dataset will be made freely available for requests that are ethically sound.

Locations